Insiders · QNRX

QNRX insider transactions

Quoin Pharmaceuticals Ltd. (QNRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for QNRX

• 70d
  SEC Form 4 filed by Stonepine Capital Management, Llc

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 123d
  SEC Form 4 filed by Chief Financial Officer Lawlor Sally Bridget

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 123d
  SEC Form 4 filed by Director Cooper Joseph Patrick

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 123d
  SEC Form 4 filed by Director Culverwell Anthony James

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 123d
  SEC Form 4 filed by Chief Executive Officer Myers Michael

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 123d
  SEC Form 4 filed by Chief Operating Officer Carter Denise P.

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 123d
  SEC Form 4 filed by Director Langer Dennis

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 123d
  SEC Form 4 filed by Director Sember Michael T

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 123d
  SEC Form 4 filed by Director Leong Natalie Ee Mun

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 127d
  New insider Stonepine Capital Management, Llc claimed ownership of 3,271,100 units of Ordinary Shares (SEC Form 3)

  3 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 188d
  SEC Form 4 filed by Chief Financial Officer Lawlor Sally Bridget

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 237d
  Director Langer Dennis bought $128,640 worth of ADSs (15,152 units at $8.49), increasing direct ownership by 1,515,200% to 15,153 units (SEC Form 4)

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 274d
  New insider Lawlor Sally Bridget claimed ownership of 440 units of ADS (SEC Form 3)

  3 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 288d
  SEC Form 4 filed by Director Leong Natalie Ee Mun

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 288d
  SEC Form 4 filed by Director Culverwell Anthony James

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 288d
  SEC Form 4 filed by Director Langer Dennis

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 361d
  Amendment: SEC Form 4 filed by Chief Operating Officer Carter Denise P.

  4/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 361d
  Amendment: SEC Form 4 filed by Chief Executive Officer Myers Michael

  4/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 371d
  SEC Form 4 filed by Director Culverwell Anthony James

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 372d
  SEC Form 4 filed by Chief Executive Officer Myers Michael

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 372d
  SEC Form 4 filed by Chief Operating Officer Carter Denise P.

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 372d
  SEC Form 4 filed by Director Leong Natalie Ee Mun

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 372d
  SEC Form 4 filed by Director Langer Dennis

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 372d
  SEC Form 4 filed by Director Cooper Joseph Patrick

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 372d
  SEC Form 4 filed by Director Sember Michael T

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 529d
  Chief Operating Officer Carter Denise P. bought $250,000 worth of Ordinary Shares (555,556 units at $0.45), increasing direct ownership by 1,180% to 602,648 units (SEC Form 4)

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 529d
  Chief Executive Officer Myers Michael bought $250,000 worth of Ordinary Shares (555,556 units at $0.45), increasing direct ownership by 1,176% to 602,808 units (SEC Form 4)

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 529d
  Director Culverwell Anthony James bought $45,000 worth of Ordinary Shares (100,000 units at $0.45), increasing direct ownership by 31,546% to 100,317 units (SEC Form 4)

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 529d
  Chief Financial Officer Dunn Gordon bought $54,999 worth of Ordinary Shares (122,221 units at $0.45), increasing direct ownership by 424% to 151,077 units (SEC Form 4)

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 546d
  SEC Form 4 filed by Director Cooper Joseph Patrick

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 546d
  SEC Form 4 filed by Chief Financial Officer Dunn Gordon

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 546d
  SEC Form 4 filed by Director Culverwell Anthony James

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 546d
  SEC Form 4 filed by Chief Operating Officer Carter Denise P.

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 546d
  SEC Form 4 filed by Director Sember Michael T

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 546d
  SEC Form 4 filed by Chief Executive Officer Myers Michael

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 546d
  SEC Form 4 filed by Director Leong Natalie Ee Mun

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 546d
  SEC Form 4 filed by Director Langer Dennis

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 636d
  Chief Financial Officer Dunn Gordon bought $23,205 worth of Ordinary Shares (28,856 units at $0.80) (SEC Form 4)

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 642d
  Chief Operating Officer Carter Denise P. bought $28,737 worth of Ordinary Shares (37,735 units at $0.76), increasing direct ownership by 403% to 47,092 units (SEC Form 4)

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 642d
  Chief Executive Officer Myers Michael bought $28,916 worth of Ordinary Shares (37,894 units at $0.76), increasing direct ownership by 405% to 47,252 units (SEC Form 4)

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 729d
  Director Langer Dennis sold $217 worth of Ordinary Shares (297 units at $0.73), decreasing direct ownership by 85% to 53 units (SEC Form 4)

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 953d
  SEC Form 4 filed by Sember Michael T

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 953d
  SEC Form 4 filed by Dunn Gordon

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 953d
  SEC Form 4 filed by Myers Michael

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 953d
  SEC Form 4 filed by Culverwell Anthony James

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 953d
  SEC Form 4 filed by Cooper Joseph Patrick

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 953d
  SEC Form 4 filed by Leong Natalie Ee Mun

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 953d
  SEC Form 4 filed by Carter Denise P.

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 953d
  SEC Form 4 filed by Langer Dennis

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 1190d
  SEC Form 3 filed by new insider Sember Michael T

  3 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 1190d
  SEC Form 3 filed by new insider Langer Dennis (Amendment)

  3/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 1190d
  SEC Form 3 filed by new insider Cooper Joseph Patrick (Amendment)

  3/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 1190d
  SEC Form 3 filed by new insider Culverwell Anthony James (Amendment)

  3/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 1190d
  SEC Form 3 filed by new insider Leong Natalie Ee Mun (Amendment)

  3/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 1253d
  SEC Form 3: New insider Myers Michael claimed ownership of 561,480,000 units of Ordinary Shares

  3 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 1253d
  SEC Form 3 filed by new insider Cooper Joseph Patrick

  3 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 1253d
  SEC Form 3: New insider Carter Denise P. claimed ownership of 561,475,000 units of Ordinary Shares

  3 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 1253d
  SEC Form 3 filed by new insider Dunn Gordon

  3 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 1253d
  SEC Form 3: New insider Culverwell Anthony James claimed ownership of 19,070,000 units of Ordinary Shares

  3 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 1253d
  SEC Form 3: New insider Langer Dennis claimed ownership of 21,005,000 units of Ordinary Shares

  3 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)